TargImmune Therapeutics AG is a startup company established in March 2016 in Basel, Switzerland. TargImmune is developing a novel cancer-targeted platform technology CTPIC in the field of immuno-oncology and personalized therapy.
iOncologi, a Florida-based clinical-stage company focused on advancing immunotherapy platform technologies, has acquired TargImmune Therapeutics.
| Building | F |
|---|---|
| Industry | Biotech |
| Research Topics | Oncology |
| Employees | 9 |
| Founding year | 2016 |
Home 
About us 
Offer 
News 
